N4-Hydroxycytidine
EIDD-1931 is a ribonucleoside analog exhibiting broad-spectrum antiviral activity against betacoronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, with low micromolar IC50 values in vitro. Its research applications extend to studying viral replication mechanisms and evaluating antiviral efficacy in both cellular and animal models of coronavirus infection.
Product Specifications
CAS Number
3258-02-4
Product Name Alternative
Beta-D-N4-hydroxycytidine; EIDD-1931
Field of Research
Infectious Disease & Virology, Molecular Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
>98%
Bioactivity
Novel antiviral
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) or in Water (up to 15 mg/ml with warming) .
Smiles
OC[C@H]1O[C@H] ([C@H] (O) [C@@H]1O) n1cc\c (=N/O) [nH]c1=O
Molecular Formula
C9H13N3O6
Molecular Weight
259.2
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
1-[ (2R,3R,4S,5R) -3,4-Dihydroxy-5- (hydroxymethyl) oxolan-2-yl]-4- (hydroxyamino) pyrimidin-2-one
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Trifunctional enzyme subunit beta, mitochondrial (HADHB) ELISA Kit
Human Trifunctional enzyme subunit beta, mitochondrial (HADHB) ELISA Kit